The oncogenic mechanism shows that FBXW7 mediates K48-linked poly-ubiquitination degradation of p100 and triggers proteasomal processing to p52, thus leading the activation of the non-canonical NF-κB signaling pathway to support the growth and survival of MM cells (Busino et al., 2012). Here, NFKB1 is linked to Miyoshi myopathy.